7 results on '"Balabanska R."'
Search Results
2. P019 Regional prevalence of IL28B SNPS rs8099917& rs12979860 in general population and in a cohort of chronic liver diseases patients
3. 156 REGIONAL PREVALENCE OF IL28B SNPS RS8099917&RS12979860 IN GENERAL POPULATION AND IN A COHORT OF CHRONIC LIVER DISEASES PATIENTS
4. 446 TIMING AND FREQUENCY OF DEPRESSION DURING HCV-TREATMENT WITH CONTROLLED-RELEASE-IFNA2B (CR2B) VS. PEGYLATED-IFNA2B (PEG2B): RESULTS FROM SELECT-2, A RANDOMIZED-OPEN-LABEL-72-WEEK-COMPARISON IN 116 TREATMENT-NAIVE PATIENTS WITH GENOTYPE-1 HCV
5. 729 MAINTENANCE PEGINTERFERON ALFA-2A TREATMENT REDUCES HBSAG LEVEL IN GENOTYPE D HBEAG-NEGATIVE INTERFERON-RESPONDERS (INTERIM RESULTS)
6. 2010 Q2WEEK CONTROLLED-RELEASE-INTERFERON-ALPHA2B + RIBAVRIN REDUCES FLU-LIKE SYMPTOMS >50% AND PROVIDES EQUIVALENT EFFICACY IN COMPARISON TO WEEKLY PEGYLATED-INTERFERON-ALPHA2B + RIBAVIRIN IN TREATMENT-NAIVE-GENOTYPE-1-CHRONIC-HEPATITIS-C: RESULTS FROM EMPOWER, A RANDOMIZED-OPEN-LABEL-12-WEEK-COMPARISON IN 133 PATIENTS
7. No correlation between the alanine aminotransferase (ALT) levelsandthe histological activity index (HAI) in patients withchronichepatitis C
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.